Common Contracts
2 similar Common Stock Agreement contracts by Hancock Jaffe Laboratories, Inc.
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT Hancock Jaffe Laboratories, Inc.Common Stock Agreement • April 16th, 2018 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated as of January 5, 2018, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”) and the Holders signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms (as it may be amended, amended and restated or otherwise modified from time to time, the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth (5th) anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, subject to adjustment as set forth in Section 2.2(a)(iii) of the Purchase Agreement, up to a number of shares of the Co
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT HANCOCK JAFFE LABORATORIES, INCCommon Stock Agreement • January 26th, 2018 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated June 15, 2017, as amended, among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”) and the investors party thereto (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, up to a number of shares of the Company’s common stock, par value $0.00001 per share, (the “Common Stock”) equal to seventy-five percent (75%) of the number of shares of Common Stock issued upon conversion of the Holder’s Note at the applicable Conversion Price under the Note (as subject to adjustm
